CrossrefInfokarte
HLA Class I Genotype as a Determinant of Human Endogenous Retrovirus-Derived Peptide Presentation and Response to Immune Checkpoint Inhibitors in Cancer: A Mechanistic and Translational Review
Annals of Cancer Research and Therapy · 2026 · 34 (2) · 65-73
DOI: 10.4993/acrt.34.65 ↗Abstract
Kein Abstract verfügbar.
EUVIMED